塞拉德尔帕在原发性胆道胆炎中的作用:系统性审查和元分析
Taimoor Ashraf1, Omar Abunada2, Nandlal Seerani2
1Nishtar Medical University, Multan, Pakistan.
BMC gastroenterology
|April 5, 2025
概括
塞拉德尔帕是一种PPAR-δ激动剂,通过改善性酸酶 (ALP) 等肝功能标志物,有效治疗一次性胆道胆炎 (PBC). 虽然有益,但需要进一步研究来评估其长期安全性和最佳剂量.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 自免疫性疾病 自免疫性疾病
背景情况:
- 初级胆道胆炎 (PBC) 是一种渐进的自身免疫性肝脏疾病.
- Ursodeoxycholic 酸 (UDCA) 是一线的,但通常是不充分的.
- 塞拉德尔帕是一种PPAR-δ激动剂,具有潜在的抗炎和抗纤维性益处.
研究的目的:
- 评估Seladelpar在PBC患者中的疗效和安全性.
- 在随机对照试验 (RCT) 中比较Seladelpar与安慰剂.
- 分析肝功能关键标志物和不良事件.
主要方法:
- 三个RCT的系统审查和元分析.
- 包括496名患有PBC的患者.
- 评估结果如ALP正常化,生化反应和安全性.
主要成果:
- 与安慰剂相比,塞拉德尔帕显著改善了ALP正常化和生化反应.
- 降低性酸酶 (ALP) 和氨酸转移酶 (ALT) 的水平.
- 报告增加了腹痛和头痛的发生率;其他不良事件类似.
结论:
- 塞拉德尔帕在改善PBC肝功能标志物方面表现出有效性.
- 长期安全评估需要进一步的研究.
- 最佳剂量和跨患者亚组的疗效需要进一步研究.
相关概念视频
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...


